Sampo plc
Sampo plc’s share buybacks 12 November 2025
Sampo plc’s share buybacks 12 November 2025
Sampo plc, stock exchange release, 13 November 2025 at 8:30 am EET
Sampo plc’s share buybacks 12 November 2025
On 12 November 2025, Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI4000552500) as follows:
| Sampo plc’s share buybacks | Aggregated daily volume (in number of shares) | Daily weighted average price of the purchased shares* | Market (MIC Code) |
| 8,085 | 9.93 | AQEU | |
| 112,509 | 9.93 | CEUX | |
| 27,571 | 9.93 | TQEX | |
| 95,331 | 9.94 | XHEL | |
| TOTAL | 243,496 | 9.94 |
* rounded to two decimals
On 5 November 2025, Sampo announced a share buyback programme of up to a maximum of EUR 150 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 6 November 2025, is based on the authorisation granted by Sampo's Annual General Meeting on 23 April 2025.
After the disclosed transactions, the company owns in total 1,229,871 Sampo A shares representing 0.05 per cent of the total number of shares in Sampo plc.
Details of each transaction are included as an appendix of this announcement.
On behalf of Sampo plc,
Morgan Stanley
For further information, please contact:
Sami Taipalus
Head of Investor Relations
tel. +358 10 516 0030
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
FIN-FSA
The principal media
www.sampo.com
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
John Crane13.11.2025 11:00:00 CET | Press release
John Crane launches Performance Plus™ - a new era in service excellence for rotating equipment
Numab Therapeutics AG13.11.2025 11:00:00 CET | Press release
Numab Therapeutics and Kaken Pharmaceutical Announce Licensing and Co-development Agreement for Multispecific Antibody NM81 in Inflammatory Bowel Disease (IBD)
Københavns Lufthavne A/S13.11.2025 10:45:40 CET | Press release
Notification on publication of statement by the Board of Directors in respect of mandatory public takeover offer
Københavns Lufthavne A/S13.11.2025 10:45:40 CET | Pressemeddelelse
Meddelelse om offentliggørelse af bestyrelsens redegørelse vedrørende pligtmæssigt overtagelsestilbud
Copenhagen Infrastructure Partners13.11.2025 10:00:00 CET | Press release
Copenhagen Infrastructure Partners and Norfund enter partnership on Mulilo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom